IMS to Present at the Friedman, Billings, Ramsey & Co. 2007 Growth Conference on May 31 at 9 a.m. ET
NORWALK, CT, May 24, 2007 – IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced that Darcie Peck, vice president, Investor Relations, will speak to investors and analysts attending the Friedman, Billings, Ramsey & Co. 2007 Growth Conference, to be held at The Grand Hyatt New York in Manhattan on May 30 - 31, 2007.
To listen to a live audio Webcast of the IMS presentation on Thursday, May 31 at 9 a.m. ET, go to: http://www.wsw.com/webcast/fbr19/rx/. A replay of the presentation will be available for seven days.
Operating in more than 100 countries, IMS Health is the world's leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.0 billion in 2006 revenue and more than 50 years of industry experience, IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations, including portfolio optimization capabilities; launch and brand management solutions; sales force effectiveness innovations; managed care and consumer health offerings; and consulting and services solutions that improve ROI and the delivery of quality healthcare worldwide. Additional information is available at http://www.imshealth.com.